Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022: Download Report, Market Opportunity at USD 100 Billion, Clinical Trial Insight by Drug Class
June 26, 2017 04:12 ET
|
KuicK Research
NEW DELHI, India, June 26, 2017 (GLOBE NEWSWIRE) -- Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 report highlights: Cancer Immunotherapy Market Assessment by ClassCancer...
Immunophotonics, Inc. Announces First Patient Dosed in a Randomized, Controlled Breast Cancer Clinical Trial for inCVAX – A Novel Investigational Immuno-Oncology Therapy
August 23, 2016 09:17 ET
|
ImmunoPhotonics, Inc.
ST. LOUIS, Aug. 23, 2016 (GLOBE NEWSWIRE) -- Immunophotonics today announces that it has dosed its first patient in a randomized & controlled clinical trial to further evaluate the efficacy of...
Intensity Therapeutics Forms Scientific Advisory Board Comprised of World-Leading Oncologists and Scientists
October 22, 2015 07:35 ET
|
Intensity Therapeutics Inc
Westport, CT, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a privately-held biotechnology company developing proprietary immune cell activating anti-cancer drug products, announced...
MMRGlobal Receives Cancer-Fighting Anti-CD20 Monoclonal Antibodies Patent in Korea
January 31, 2014 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Jan 31, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Receives Additional Biotech Patent Protection in U.S., Mexico and Japan for Cancer Vaccines
October 02, 2013 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Oct 2, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Adds Japan & South Korea to China in Filing of Cancer Fighting Patent Under Expedited Patent Allowance Program
August 26, 2013 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Aug 26, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Files Additional Cancer Fighting Patent in China Under Expedited Patent Allowance Program
August 19, 2013 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Aug 19, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Receives Cancer Fighting Vaccine Patent in Hong Kong
June 25, 2013 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Jun 25, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") today announced that it has received another biotechnology patent, this one in Hong Kong. The Company has...
Dr. Ivor Royston, Oncologist, Scientist, Entrepreneur-Financier and Founding Father of San Diego Biotech, Joins MMRGlobal Board
May 28, 2013 08:20 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - May 28, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company") today announced that Ivor Royston, M.D. has agreed to join the Company's Board of Directors...
MMRGlobal Announces U.S. Patent for Cancer Fighting Anti-CD20 Monoclonal Antibody
April 15, 2013 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Apr 15, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") today announced that the United States Patent and Trademark Office has issued a Notice of Allowance...